<?xml version='1.0' encoding='utf-8'?>
<document id="19665485"><sentence text="Pharmacokinetics and drug-drug interactions of antiretrovirals: an update." /><sentence text="Current antiretroviral treatment has allowed HIV infection to become a chronic manageable condition with many HIV patients living longer" /><sentence text=" However, available antiretrovirals are not without limitations, for example the development of resistance and adverse effects" /><sentence text=" Consequently, new drugs in existing and novel classes are urgently required to provide viable treatment options to patients with few remaining choices" /><sentence text=" Darunavir, etravirine, maraviroc and raltegravir have been recently approved for treatment-experienced patients and other agents such as rilpivirine, vicriviroc and elvitegravir are currently under phase III study"><entity charOffset="1-10" id="DDI-PubMed.19665485.s5.e0" text="Darunavir" /><entity charOffset="12-22" id="DDI-PubMed.19665485.s5.e1" text="etravirine" /><entity charOffset="24-33" id="DDI-PubMed.19665485.s5.e2" text="maraviroc" /><entity charOffset="38-49" id="DDI-PubMed.19665485.s5.e3" text="raltegravir" /><entity charOffset="138-149" id="DDI-PubMed.19665485.s5.e4" text="rilpivirine" /><entity charOffset="151-161" id="DDI-PubMed.19665485.s5.e5" text="vicriviroc" /><entity charOffset="166-178" id="DDI-PubMed.19665485.s5.e6" text="elvitegravir" /><pair ddi="false" e1="DDI-PubMed.19665485.s5.e0" e2="DDI-PubMed.19665485.s5.e0" /><pair ddi="false" e1="DDI-PubMed.19665485.s5.e0" e2="DDI-PubMed.19665485.s5.e1" /><pair ddi="false" e1="DDI-PubMed.19665485.s5.e0" e2="DDI-PubMed.19665485.s5.e2" /><pair ddi="false" e1="DDI-PubMed.19665485.s5.e0" e2="DDI-PubMed.19665485.s5.e3" /><pair ddi="false" e1="DDI-PubMed.19665485.s5.e0" e2="DDI-PubMed.19665485.s5.e4" /><pair ddi="false" e1="DDI-PubMed.19665485.s5.e0" e2="DDI-PubMed.19665485.s5.e5" /><pair ddi="false" e1="DDI-PubMed.19665485.s5.e0" e2="DDI-PubMed.19665485.s5.e6" /><pair ddi="false" e1="DDI-PubMed.19665485.s5.e1" e2="DDI-PubMed.19665485.s5.e1" /><pair ddi="false" e1="DDI-PubMed.19665485.s5.e1" e2="DDI-PubMed.19665485.s5.e2" /><pair ddi="false" e1="DDI-PubMed.19665485.s5.e1" e2="DDI-PubMed.19665485.s5.e3" /><pair ddi="false" e1="DDI-PubMed.19665485.s5.e1" e2="DDI-PubMed.19665485.s5.e4" /><pair ddi="false" e1="DDI-PubMed.19665485.s5.e1" e2="DDI-PubMed.19665485.s5.e5" /><pair ddi="false" e1="DDI-PubMed.19665485.s5.e1" e2="DDI-PubMed.19665485.s5.e6" /><pair ddi="false" e1="DDI-PubMed.19665485.s5.e2" e2="DDI-PubMed.19665485.s5.e2" /><pair ddi="false" e1="DDI-PubMed.19665485.s5.e2" e2="DDI-PubMed.19665485.s5.e3" /><pair ddi="false" e1="DDI-PubMed.19665485.s5.e2" e2="DDI-PubMed.19665485.s5.e4" /><pair ddi="false" e1="DDI-PubMed.19665485.s5.e2" e2="DDI-PubMed.19665485.s5.e5" /><pair ddi="false" e1="DDI-PubMed.19665485.s5.e2" e2="DDI-PubMed.19665485.s5.e6" /><pair ddi="false" e1="DDI-PubMed.19665485.s5.e3" e2="DDI-PubMed.19665485.s5.e3" /><pair ddi="false" e1="DDI-PubMed.19665485.s5.e3" e2="DDI-PubMed.19665485.s5.e4" /><pair ddi="false" e1="DDI-PubMed.19665485.s5.e3" e2="DDI-PubMed.19665485.s5.e5" /><pair ddi="false" e1="DDI-PubMed.19665485.s5.e3" e2="DDI-PubMed.19665485.s5.e6" /><pair ddi="false" e1="DDI-PubMed.19665485.s5.e4" e2="DDI-PubMed.19665485.s5.e4" /><pair ddi="false" e1="DDI-PubMed.19665485.s5.e4" e2="DDI-PubMed.19665485.s5.e5" /><pair ddi="false" e1="DDI-PubMed.19665485.s5.e4" e2="DDI-PubMed.19665485.s5.e6" /><pair ddi="false" e1="DDI-PubMed.19665485.s5.e5" e2="DDI-PubMed.19665485.s5.e5" /><pair ddi="false" e1="DDI-PubMed.19665485.s5.e5" e2="DDI-PubMed.19665485.s5.e6" /></sentence><sentence text=" Clinical studies are necessary to optimise potential treatment combinations and to manage drug-drug interactions to help avoid toxicity or therapy failure" /><sentence text=" This review aims to summarise the pharmacokinetics and key drug-drug interaction studies for newly available antiretrovirals and those in development" /><sentence text=" Further information regarding drug-drug interactions of well established antiretrovirals and those recently approved are readily available online at sites such as http://www" /><sentence text="hiv-druginteractions" /><sentence text="org, http://www" /><sentence text="clinicaloptions" /><sentence text="com/hiv, http://hivinsite" /><sentence text="ucsf" /><sentence text="edu" /><sentence text=" This article forms part of a special issue of Antiviral Research marking the 25th anniversary of antiretroviral drug discovery and development, Vol 85, issue 1, 2010" /><sentence text="" /></document>